Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Lexeo Therapeutics Announces Closing of Public Offering and Concurrent Private Placement and Exercise in Full of the Underwriters’ Option
-
TORONTO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (Upstream: QNTM) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company...
-
MONTRÉAL, 17 oct. 2025 (GLOBE NEWSWIRE) -- PyroGenèse Inc. (« PyroGenèse ») (TSX : PYR) (OTCQX : PYRGF) (FRA : 8PY1), chef de file en matière d’innovation dans les procédés et l’ingénierie à...
-
MONTREAL, Oct. 17, 2025 (GLOBE NEWSWIRE) -- PyroGenesis Inc. (“PyroGenesis”) (TSX: PYR) (OTCQX: PYRGF) (FRA: 8PY1), the leader in innovating for ultra-high temperature processes and engineering, and...
-
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | FSE: ZK9)...
-
Lexeo Therapeutics Announces Pricing of Public Offering and Concurrent Private Placement
-
Not for distribution to U.S. newswire services or for release, publication, distribution or dissemination, directly or indirectly, in whole or in part, into the United StatesTORONTO, Oct. 16, 2025...
-
MINK Ventures Corp. Closes $731,518 in First Tranche of Non-Brokered Private Placement
-
ROCKVILLE, Maryland, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Theriva™ Biologics (NYSE American: TOVX), («Theriva» o la «empresa»), una empresa diversificada de fase clínica que desarrolla terapias...
-
COSTA MESA, Calif., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Insight Investments, LLC, today announced that it has achieved its 10th consecutive completion and recertification of the Service Organization...